CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Magnetically Controlled Capsule Endoscopydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05004012
NCT05004012N/ACompleted
CompareCT.gov

AnX/Ankon Navicam Magnetically Controlled Capsule Endoscopy Feasibility Study in Gastric Motility

University of California, Los Angeles·interventional·Posted Aug 13, 2021·Updated Apr 29, 2026

In Brief

A clinical study evaluating Magnetically Controlled Capsule Endoscopy for Gastroparesis and Dyspepsia. Completed, enrolled 20 participants across 1 site.

Detailed Summary

This is a feasibility study to assess the utility of magnetically controlled capsule endoscopy in the evaluation of gastroparesis and functional dyspepsia

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGastroparesis, Dyspepsia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedAug 13, 2021
Enrollment StartDec 1, 2021
Primary CompletionMay 22, 2023
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 4.9 years ago

Interventions

Magnetically Controlled Capsule Endoscopydevice

This is a diagnostic device for gastric disorders used to diagnose mucosal abnormalities. In this study it will be evaluated for use in gastric motility.